the relevance of this finding to humans remains uncertain, and UK SmPCs for licensed GLP-1 analogues note this as a precautionary concern rather than a confirmed human risk [6] Sermorelin's risks include fluid retention, joint discomfort, and potential stimulation of pre-existing growth-dependent pathologies
Peake J, Suzuki K
It accomplishes this primarily by inhibiting certain metabolic enzymes in the liver and intestinal wall that would otherwise break down beneficial compounds before they can be utilized by the body
This peptide generates similar increases in growth hormone secretion, but without the appetite stimulation and increase in cortisol, acetylcholine, prolactin, and aldosterone seen with other peptides in its class
Understanding GLP-1 for Weight Loss Think of GLP-1s as your secret weapons on your weight loss journey
Researchers say these findings suggest GLP-1 drugs may play a role in treating addictive behaviors, but its too soon to reliably tell